Analysis of the necessary radioprotection procedures in manufacture of iodine-125 sources used in brachytherapy: A preliminary study

被引:1
|
作者
Souza, Carla D. [1 ]
Rostelato, Maria Elisa C. M. [1 ]
Zeituni, Carlos A. [1 ]
Moura, Joao A. [1 ]
Moura, Eduardo S. [1 ]
Fonseca, Katia [1 ]
Feher, Anselmo [1 ]
机构
[1] IPEN, CNEN, SP, BR-05508000 Sao Paulo, Brazil
关键词
Prostate cancer; Brachytherapy; Iodine-125; Radioactive installation; Radiation protection; Dosimetry; PROSTATE-CANCER; SILVER; EYE;
D O I
10.1016/j.pnucene.2010.08.011
中图分类号
TL [原子能技术]; O571 [原子核物理学];
学科分类号
0827 ; 082701 ;
摘要
The estimates for the year 2009 predict that 466,730 new cancer cases would occur in Brazil. Prostate cancer is the second most incident in our country, with almost 50,000 new cases in 2009. Brachytherapy, a type of radiotherapy. with iodine-125 sources is an important form of treatment for this kind of cancer. The "Instituto de Pesquisas Energeticas e Nucleares" (Institute for Nuclear and Energy Research - IPEN) created a project to produce a national prototype of these sources and develop a facility for local production. Manufacturing seeds locally will diminish the overall treatment cost making such treatment available to a larger number of patients. While the laboratory is under development, the IPEN imports and distributes seeds. This work aims to present and evaluate the radiological protection procedures applied to imported sources in order to assist in the setup of the new laboratory. Although iodine-125 presents low energy photons, around 29 key, local and personal dosimeters are used during the separation and distribution process of seeds as described in CNEN NN 3.01 standard "Diretrizes Basicas de Protecao Radiologica" (Radiological Protection Basic Guidelines). All testing has demonstrated that there is no area contamination and very low exposure, suggesting that the application of the standards outlined in CNEN NN 3.01 has been effective. As a result of this work, a new dosimeter should be installed and evaluated in a future study. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:66 / 72
页数:7
相关论文
共 39 条
  • [21] Analysis of the relationship between prescribed dose and dosimetric advantage of real-time intraoperatively built custom-linked seeds in iodine-125 prostate brachytherapy
    Katsumi Hirose
    Masahiko Aoki
    Mariko Sato
    Hiroyoshi Akimoto
    Yasuhiro Hashimoto
    Atsushi Imai
    Noritaka Kamimura
    Hideo Kawaguchi
    Yoshiomi Hatayama
    Ichitaro Fujioka
    Mitsuki Tanaka
    Chikara Ohyama
    Yoshihiro Takai
    Radiation Oncology, 12
  • [22] Analysis of the relationship between prescribed dose and dosimetric advantage of real-time intraoperatively built custom-linked seeds in iodine-125 prostate brachytherapy
    Hirose, Katsumi
    Aoki, Masahiko
    Sato, Mariko
    Akimoto, Hiroyoshi
    Hashimoto, Yasuhiro
    Imai, Atsushi
    Kamimura, Noritaka
    Kawaguchi, Hideo
    Hatayama, Yoshiomi
    Fujioka, Ichitaro
    Tanaka, Mitsuki
    Ohyama, Chikara
    Takai, Yoshihiro
    RADIATION ONCOLOGY, 2017, 12
  • [23] Beyond surgical resection: evaluating stereotactic brachytherapy iodine-125 for low-grade gliomas: a systematic review and meta-analysis
    Palavani, Lucca B.
    Verly, Gabriel
    Borges, Pedro
    Neto, Luis
    Almeida, Miguel
    Leite, Marianna
    Oliveira, Leonardo B.
    Batista, Savio
    Bertani, Raphael
    Polverini, Allan Dias
    de Macedo Filho, Leonardo
    Paiva, Wellingson
    NEUROSURGICAL REVIEW, 2024, 47 (01)
  • [24] Iodine-125 radioactive seed brachytherapy as a treatment for spine and bone metastases: A systematic review and meta-analysis
    Sharma, Ruhi
    Sagoo, Navraj S.
    Haider, Ali S.
    Sharma, Neha
    Haider, Maryam
    Sharma, Ishaan K.
    Igbinigie, Matthew
    Aya, Kessiena L.
    Aoun, Salah G.
    Vira, Shaleen
    SURGICAL ONCOLOGY-OXFORD, 2021, 38
  • [25] Predictors of Local Recurrence and Progression-Free Survival in Iodine-125 brachytherapy-treated Uveal Melanomas: A modern institutional study
    Gurayah, Aaron A.
    Peters, Vanessa A.
    Jin, William
    Kalahasty, Karthik
    Kwon, Deukwoo
    Zhao, Wei
    Patel, Nirav V.
    Markoe, Arnold M.
    Correa, Zelia M.
    Studenski, Matthew T.
    Harbour, J. William
    Samuels, Stuart E.
    OCULAR ONCOLOGY AND PATHOLOGY, 2022, 8 (03) : 175 - 180
  • [26] Seed migration after transperineal interstitial prostate brachytherapy by using loose seeds: Japanese prostate cancer outcome study of permanent iodine-125 seed implantation (J-POPS) multi-institutional cohort study
    Nakano, Masahiro
    Yorozu, Atsunori
    Saito, Shiro
    Sugawara, Akitomo
    Maruo, Shinichiroh
    Kojima, Shinsuke
    Kikuchi, Takashi
    Fukushima, Masanori
    Dokiya, Takushi
    Yamanaka, Hidetoshi
    RADIATION ONCOLOGY, 2015, 10
  • [27] Efficacy and safety of iodine-125 radioactive seeds brachytherapy for advanced non-small cell lung cancer-A meta-analysis
    Zhang, Wenchao
    Li, Jiawei
    Li, Ran
    Zhang, Ying
    Han, Mingyong
    Ma, Wei
    BRACHYTHERAPY, 2018, 17 (02) : 439 - 448
  • [28] Analysis of radioactive implant migration in patients treated with iodine-125 seeds for permanent prostate brachytherapy with MRI-classified median lobe hyperplasia
    Muraki, Koichiro
    Hattori, Chikayuki
    Ogo, Etsuyo
    Suefuji, Hiroaki
    Eto, Hidehiro
    Tsuji, Chiyoko
    Miyata, Yusaku
    Abe, Toshi
    Chikui, Katsuaki
    Nakiri, Makoto
    Igawa, Tsukasa
    Kakuma, Tatsuyuki
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2021, 13 (03) : 254 - 262
  • [29] Testosterone Recovery after Neoadjuvant Gonadotropin-Releasing Hormone Antagonist versus Agonist on Permanent Iodine-125 Seed Brachytherapy in Prostate Cancer Patients: A Propensity Score Analysis
    Iwata, Takehiro
    Maruyama, Yuki
    Kawada, Tatsushi
    Sadahira, Takuya
    Katayama, Satoshi
    Takamoto, Atsushi
    Sako, Tomoko
    Wada, Koichiro
    Edamura, Kohei
    Kobayashi, Yasuyuki
    Araki, Motoo
    Watanabe, Masami
    Watanabe, Toyohiko
    Nasu, Yasutomo
    ACTA MEDICA OKAYAMA, 2021, 75 (06) : 705 - 711
  • [30] Predictive factors of acute urinary morbidity after iodine-125 brachytherapy for localised prostate cancer: a phase 2 study
    Salem, N
    Simonian-Sauve, M
    Rosello, R
    Alzieu, C
    Gravis, G
    Maraninchi, D
    Bladou, F
    RADIOTHERAPY AND ONCOLOGY, 2003, 66 (02) : 159 - 165